Our Commercialization business is led by Maximax International Inc. and involves several business models
Integrated Service Provider for Commercialization
In this model, Maximax International executes distribution agreements for local or regional markets and sub-contract warehousing, importation and logistics to local distributors. We undertake the responsibility of marketing, registration and overall execution of the contract. This model enables pharmaceutical or device companies to optimize sales in targeted markets leveraging the marketing capabilities of our company and considering that most distributors in international regions have limited marketing expertise or are mostly focusing resources in certain cities and counties. Another version of this model is doable when Maximax International Inc. co-signs distribution agreements with distributors.
Functional Service Provider for Commercialization
This line of services involves the different aspects associated with commercialization, including:
Market research and feasibility studies
Regulatory submission and approval
Distributors’ selection and management
Resourcing and staffing of medical representatives and marketing campaign
In 2009, MPR initiated a new business unit supporting contract manufacturing in the Middle East and North Africa (MENA) region and in China. Mr. Abdul Razzaq Yousef has joined Maximax International Inc. leading its contract manufacturing business unit. This unit seeks to manufacture leading biological and pharmaceutical products for Asia markets, focusing on vaccines, diabetes, oncology and cardiology products.